Clinical trial
Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_CCRT Trial)
NCT03239613 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer: a Prospective Exploratory Trial (POHIM_CCRT Trial)
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2017
- Completion date
- April 28, 2023
- Enrollment
- 84 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cervix cancer, chemotherapy, concurrent, hypofractionated dose, radiotherapy, adjuvant, radiotherapy, intensity-modulated